Natco Other Operating Expenses from 2010 to 2024
| NATCOPHARM | 1,376 38.05 2.84% |
Other Operating Expenses | First Reported 2011-09-30 | Previous Quarter 6 B | Current Value 13.7 B | Quarterly Volatility 2.2 B |
Check Natco Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natco Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 B, Interest Expense of 180 M or Total Revenue of 42 B, as well as many indicators such as . Natco financial statements analysis is a perfect complement when working with Natco Pharma Valuation or Volatility modules.
Natco | Other Operating Expenses |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Natco Stock
Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.